Wednesday, Feb 19 2020 | Time 20:03 Hrs(IST)
  • SBI ATM in Kaithal uprooted, Rs 22 60 lakh stolen
  • Kejriwal meets Shah, discusses issues related to Delhi
  • MP CM touches on commissionerate system
  • PM Modi led panel decides names for CVC and CIC amid Congress protest
  • Man from Nanded arrested for raping his own married daughter
  • All free schemes to continue for next five years: Kejriwal
  • Bengaluru go down 2-1 to Maziya S&RC in AFC cup qualifying
  • HP CM dedicates projects worth Rs 350 cr in Kangra
  • Cheteshwar Pujara signs up six-game deal with English county Gloucestershire
  • Trump's visit: First standalone visit by a US President to India
  • Paswan interacts with Industry representatives
  • Modi will visit B'desh next month for Bangabandhu centenary: FM
  • Cong slams Govt over 'selection' of CVC, VC; says entire rules and regulations vitiated
  • U-17 Football: India women beat Romania 1-0 in 2nd friendly match

Well-prepared laboratories are first line of defence against novel Coronavirus in Europe

Well-prepared laboratories are first line of defence against novel Coronavirus in Europe

Copenhagen, Feb 11 (UNI) Timely detection of a contagious pathogen is vital to controlling its spread.

In response to the emergency of novel coronavirus (2019-nCoV), WHO is working closely with a network of designated laboratories in the WHO European Region and other WHO regions to ensure that every country has the capacity and resources required to quickly test, report and respond to any suspected cases of the disease. In particular, WHO/Europe is facilitating shipment of testing kits, within a month of the virus first being isolated.

Working largely unseen, in the context of routine disease surveillance or in the event of acute disease outbreaks, laboratories are a vital link in the chain of activities required to keep populations safe from diseases.

Recognising this, WHO/Europe and the European Centre for Disease Prevention and Control (ECDC) moved quickly following identification of the novel virus on January 7 last to identify laboratory needs and capacities in the European Region.

WHO/Europe and partners established a roster of 6 international laboratories in the Region to act as regional referral laboratories to provide testing support to laboratories working at country level. These laboratories are located in France, Germany, the Netherlands, the Russian Federation and the United Kingdom.

A network of nationally designated laboratories for testing of 2019-nCoV was also activated, primarily building on the existing laboratory network within the Global Influenza Surveillance and Response System (GISRS).

Thanks to China’s swift release of the full virus sequence, the first protocol for diagnostic testing of samples collected from potentially infected patients and their contacts became available in early January. This enabled 31 countries in the Region to rapidly establish testing capacities.

WHO also commissioned the manufacturing of test kits for global distribution to the designated 2019-nCoV laboratories. WHO/Europe is facilitating a first round of shipment of 192 kits (containing 100 tests each) to 20 laboratories in the Region. Globally, WHO is making 250 000 tests available to 159 laboratories.

Countries with no testing capacity can send their samples to the WHO appointed 2019-nCoV referral laboratories for testing. New 2019-nCoV laboratories are also encouraged to send the first 5 positive and the first 10 negative 2019-nCoV samples to their referral laboratories for confirmation of test results.

To ensure rapid and free-of-charge shipment of samples, WHO repurposed the Shipping Fund Project established by the GISRS. In addition, WHO and partners are developing an external quality assurance programme for national 2019-nCoV laboratories.

This rapid expansion of testing capacity is increasing preparedness in each country to reduce the risk of infection and spread of the virus. Available data on the spread of the virus changes daily. The vast majority of patients around the world is in China, and China’s strategy to contain the outbreak at its epicentre is proving effective, with only a few hundred cases so far in the rest of the world.

This is the European Region’s window of opportunity to prepare in every country for a potential introduction of 2019-nCoV. This includes strengthening capacities to find, test and care for patients; to prevent and control infections; and to communicate risks with the public.


More News
Water makes up 0 25 pc of Jupiter's atmosphere: NASA's Juno mission

Water makes up 0 25 pc of Jupiter's atmosphere: NASA's Juno mission

19 Feb 2020 | 7:30 PM

Los Angeles, Feb 19 (UNI) According to NASA's Jet Propulsion Laboratory (JPL), Juno mission in its first result on the amount of water in Jupiter's atmosphere has found out that water makes up about 0.25 percent of the molecules in Jupiter's atmosphere - almost three times that of the Sun.

see more..

Post-Brexit UK to have no place for low-skilled workers

19 Feb 2020 | 6:50 PM

London, Feb 19 (UNI) Britain will not grant visas to low-skilled workers under its newly unveiled immigration scheme after Brexit, UK Home Office said on Wednesday.

see more..

China revokes press cards of 3 WSJ journalists

19 Feb 2020 | 6:23 PM

Beijing, Feb 19 (UNI) The press cards of three Wall Street Journal journalists who are based in Beijing will be revoked from Wednesday, China's Foreign Ministry spokesperson Geng Shuang said.

"The Chinese people do not welcome media that use racially discriminatory languages and maliciously slander and attack China," Xinhua quoted Geng during an online press briefing.

see more..
Fruit carrying citrus disease found in Australia

Fruit carrying citrus disease found in Australia

19 Feb 2020 | 5:48 PM

Canberra, Feb 19 (UNI) A killer disease capable of devastating Australia's citrus industry was found in the country, biosecurity officials have confirmed, Department of Agriculture, Water and Environment on Wednesday confirmed that officers recently seized fruit items entering Australia with citrus canker.

see more..
No trade deal during Trump India visit

No trade deal during Trump India visit

19 Feb 2020 | 4:42 PM

Washington, Feb 19 (UNI) India and the United States won't sign a trade deal during President Donald Trump's February 24-25 visit to New Delhi.

see more..